Your browser doesn't support javascript.
loading
Pyridoxine for treatment of levetiracetam-induced behavioral adverse events: A randomized double-blind placebo-controlled trial.
Cheraghmakani, Hamed; Rezapour, Maryam; Asghari, Faezeh; Alizadeh-Navaei, Reza; Ghazaeian, Monireh; Tabrizi, Nasim.
Afiliação
  • Cheraghmakani H; Neurology Department, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
  • Rezapour M; Psychiatry and Behavioural Sciences Research Center, Addiction Institute, Department of Psychiatry, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
  • Asghari F; Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
  • Alizadeh-Navaei R; Gastrointestinal Cancer Research Center, Non-communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
  • Ghazaeian M; Pharmaceutical Research Center, Department of Clinical Pharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
  • Tabrizi N; Neurology Department, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran. Electronic address: n.tabrizi@mazums.ac.ir.
Epilepsy Behav ; 136: 108938, 2022 11.
Article em En | MEDLINE | ID: mdl-36228485
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piracetam / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Epilepsia Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piracetam / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Epilepsia Idioma: En Ano de publicação: 2022 Tipo de documento: Article